ProQR Therapeutics N.V. (PRQR)

ProQR Therapeutics Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	92.41	149.41	118.93	94.78	187.52
Cash & Short-Term Investments	92.41	149.41	118.93	94.78	187.52
Cash Growth	-38.15%	25.63%	25.48%	-49.46%	147.27%
Other Current Assets	7.71	4.44	2.06	59.69	3.96
Total Current Assets	100.13	153.85	120.99	154.46	191.48
Net Property, Plant & Equipment	12.63	14.11	16.9	16.24	17.47
Long-Term Investments	-	-	-	0.62	0.63
Total Assets	112.76	167.96	137.88	171.32	209.58
Accounts Payable	0.3	0.02	1.54	0.39	0.19
Short-Term Debt	-	-	-	2.5	-
Current Portion of Leases	-	-	-	1.39	-
Unearned Revenue	-	-	-	5.64	-
Other Current Liabilities	8.17	10.8	10.48	11.07	15.99
Total Current Liabilities	32.44	38.9	34.2	20.99	27.6
Long-Term Debt	4.87	4.58	4.29	4.27	44.09
Long-Term Leases	11.09	12.63	15.44	13.81	16.28
Other Long-Term Liabilities	38.95	51.37	64.74	-	19.8
Total Long-Term Liabilities	54.91	68.59	84.47	18.08	80.17
Total Liabilities	63.38	79.4	96.49	104.64	96.35
Common Stock	4.31	4.31	3.37	3.37	3
Additional Paid-in Capital	483.88	483.81	412.89	412.54	398.31
Accumulated Other Comprehensive Income	28.69	27.6	25.98	30.26	30.3
Retained Earnings	-467.51	-427.16	-400.85	-379.11	-317.77
Total Common Shareholders' Equity	49.37	88.56	41.39	67.07	113.83
Minority Interest	-	-	-	-0.38	-0.6
Shareholders' Equity	49.37	88.56	41.39	66.68	113.23
Total Liabilities & Equity	112.76	167.96	137.88	171.32	209.58
Total Debt	15.96	17.22	19.73	21.97	60.37
Net Cash (Debt)	76.45	132.19	99.19	72.8	127.15
Net Cash Growth	-42.17%	33.27%	36.24%	-42.74%	205.94%
Net Cash Per Share	0.73	1.54	1.22	1.02	1.98
Book Value	49.37	88.56	41.39	67.07	113.83
Book Value Per Share	0.47	1.03	0.51	0.94	1.77
Tangible Book Value	49.37	88.56	41.39	67.07	113.83
Tangible Book Value Per Share	0.47	1.03	0.51	0.94	1.77

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q